Insider Transactions in Q2 2022 at Travere Therapeutics, Inc. (TVTX)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 12
2022
|
Elizabeth E Reed SVP, GC & CORPORATE SECRETARY |
SELL
Open market or private sale
|
Direct |
1,050
-2.45%
|
$22,050
$21.51 P/Share
|
|
May 11
2022
|
Roy D. Baynes |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+13.04%
|
-
|
|
May 11
2022
|
Suzanne Louise Bruhn |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+21.05%
|
-
|
|
May 11
2022
|
Timothy Coughlin |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+7.32%
|
-
|
|
May 11
2022
|
Gary A Lyons |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+6.98%
|
-
|
|
May 11
2022
|
Jeffrey A Meckler |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+4.11%
|
-
|
|
May 11
2022
|
John A Orwin |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+14.37%
|
-
|
|
May 11
2022
|
Sandra Poole |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+19.35%
|
-
|
|
May 11
2022
|
Steve Aselage Director |
SELL
Open market or private sale
|
Direct |
2,575
-1.72%
|
$54,075
$21.92 P/Share
|
|
May 11
2022
|
Ron Squarer |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+14.37%
|
-
|
|
May 11
2022
|
Brinkley Ruth Williams |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+26.67%
|
-
|
|
May 11
2022
|
William E. Rote SENIOR VICE PRESIDENT, R&D |
SELL
Open market or private sale
|
Direct |
1,563
-1.74%
|
$32,823
$21.73 P/Share
|
|
May 11
2022
|
Sandra Calvin SVP, CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
445
-1.23%
|
$9,345
$21.92 P/Share
|
|
May 11
2022
|
Laura Clague Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,375
-3.71%
|
$28,875
$21.51 P/Share
|
|
May 10
2022
|
Sandra Calvin SVP, CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
436
-1.19%
|
$9,156
$21.51 P/Share
|
|
May 10
2022
|
Laura Clague Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
825
-2.18%
|
$17,325
$21.51 P/Share
|
|
May 10
2022
|
Elizabeth E Reed SVP, GC & CORPORATE SECRETARY |
SELL
Open market or private sale
|
Direct |
900
-2.06%
|
$18,900
$21.51 P/Share
|